Table 1. Characteristics of men with psoriasis and controls.
Parameter | Patients with psoriasis (n = 85) [mean ± SD] |
Controls (n = 65) [mean ± SD] |
p |
---|---|---|---|
Age (years) | 47 ± 14 | 44 ± 13 | NS |
PASI | 17 ± 9 | - | - |
Disease duration (years) | 18 ± 13 | - | - |
BSA (%) | 26 ± 19 | - | - |
BMI (kg/m2) | 28 ± 5 | 26 ± 3 | 0.003 |
Systolic blood pressure (mm Hg) |
1.3 x 102 ± 0.1 x 102 | 1.3 x 102 ± 0.1 x 102 | NS |
Diastolic blood pressure (mm Hg) | 81 ± 10 | 80 ± 8 | NS |
Total cholesterol (mg/dl) | 2.1 x 102 ± 0.4 x 102 | 1.9 x 102 ± 0.4 x 102 | 0.01 |
LDL-cholesterol (mg/dl) | 1.2 x 102 ±0.3 x 102 | 1.3 x 102 ± 0.4 x 102 | NS |
HDL-cholesterol (mg/dl) | 50 ± 13 | 54 ± 15 | NS |
TG (mg/dl) | 1.6 x 102 ± 0.8 x 102 | 1.3 x 102 ± 0.7 x 102 | NS |
Uric acid (mg/dl) | 6.1 ± 1.6 | 5.7 ± 1.1 | NS |
Lipase (U/l) | 35 ± 19 | 32± 16 | NS |
Interleukin 6 (pg/ml) | 4.3 ± 4.6 | 0.700 ± 0.005 | <0.0001 |
Interleukin 18 (pg/ml) | 2.8 x 102 ± 1.2 x 102 | 2.2 x 102 ± 1 x 102 | 0.006 |
Cortisol (ng/ml) | 1.3 x 102 ± 0.4 x 102 | 1.3 x 102 ± 0.4 x 102 | NS |
25-hydroxyvitamin D3 (ng/ml) | 12 ± 5 | 22± 9 | <0.0001 |
Beck Depression Inventory (points) | 13 ± 11 | 4.5 ± 4.4 | <0.0001 |
BMI, body mass index; BSA, body surface area affected by psoriatic lesions; NS, non-significant (p>0.05); PASI, Psoriasis Area Severity Index; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TG, triglycerides; SD, standard deviation